Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 34 citing articles:

Contemporary medical, device, and surgical therapies for obesity in adults
Carolina M. Perdomo, Ricardo V. Cohen, Priya Sumithran, et al.
The Lancet (2023) Vol. 401, Iss. 10382, pp. 1116-1130
Closed Access | Times Cited: 365
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
Anders Boisen Jensen, Frida Renström, Stefan Aczél, et al.
Obesity Surgery (2023) Vol. 33, Iss. 4, pp. 1017-1025
Open Access | Times Cited: 89
Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery
Jessica Mok, Mariam O. Adeleke, Adrian Brown, et al.
JAMA Surgery (2023) Vol. 158, Iss. 10, pp. 1003-1003
Open Access | Times Cited: 75
Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrence
Natia Murvelashvili, Luyu Xie, Jeffrey N. Schellinger, et al.
Obesity (2023) Vol. 31, Iss. 5, pp. 1280-1289
Open Access | Times Cited: 43
Pharmacological Support for the Treatment of Obesity—Present and Future
Marcin Kosmalski, Kacper Deska, Bartłomiej Bąk, et al.
Healthcare (2023) Vol. 11, Iss. 3, pp. 433-433
Open Access | Times Cited: 25
Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis
Deep Dutta, Lakshmi Nagendra, Ameya Joshi, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1653-1664
Closed Access | Times Cited: 13
Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis
Federica Vinciguerra, Carla Di Stefano, Roberto Baratta, et al.
Obesity Surgery (2024) Vol. 34, Iss. 2, pp. 303-309
Open Access | Times Cited: 9
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Suboptimal Initial Clinical Response and Weight Gain Recurrence After Bariatric Surgery: a Systematic Review and Meta-analysis
Yuntao Nie, Yiran Zhang, Baoyin Liu, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1
Towards an adiposity-related disease framework for the diagnosis and management of obesities
Carolina M. Perdomo, Icíar Avilés-Olmos, Dror Dicker, et al.
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 5, pp. 795-807
Open Access | Times Cited: 22
Adjuvant Glucose-Like Peptide 1 Receptor Agonist Therapy for Suboptimal Weight Loss After Bariatric Surgery: a Systematic Review
Alexandre Dréant, Claire Blanchard, David Jacobi
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1846-1854
Closed Access | Times Cited: 8
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment
Caroline K. Kramer, Matthew Retnakaran, Luciana Verçoza Viana
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 8, pp. e1634-e1641
Closed Access | Times Cited: 8
Revision/Conversion Surgeries After One Anastomosis Gastric Bypass—An Experts’ Modified Delphi Consensus
Mohammad Kermansaravi, Sonja Chiappetta, Chetan Parmar, et al.
Obesity Surgery (2024) Vol. 34, Iss. 7, pp. 2399-2410
Closed Access | Times Cited: 7
Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery
Jean‐Baptiste Bonnet, Sarah Tournayre, Jean Anitcheou, et al.
Obesity (2023) Vol. 32, Iss. 1, pp. 50-58
Open Access | Times Cited: 15
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity
L Horvath, Miloš Mráz, Edward B. Jude, et al.
Drugs (2024) Vol. 84, Iss. 8, pp. 933-952
Open Access | Times Cited: 5
Glucagon-like peptide-1 receptor agonists for post-bariatric surgery weight regain and insufficient weight loss: A systematic review
Kevin Gracia Pratama, Heri Nugroho, Antoninus Hengky, et al.
Obesity Medicine (2024) Vol. 46, pp. 100533-100533
Closed Access | Times Cited: 4
Adjuvant and Neo-Adjuvant Anti-Obesity Medications and Bariatric Surgery: A Scoping Review
Theo Sher, Michelle Y. McGee, Christopher DuCoin, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 2, pp. 377-402
Closed Access | Times Cited: 4
Safety and efficacy of glucagon‐like peptide‐1 (GLP‐1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta‐analysis
Ali Esparham, Ali Mehri, Amin Dalili, et al.
Obesity Reviews (2024) Vol. 25, Iss. 11
Open Access | Times Cited: 4
The Landscape of Obesity Education Worldwide — Are We Doing Enough? Scoping Review of Content of Obesity Educational Interventions in Medical Schools and Residency Programs
Wahiba Elhag, Walid El Ansari
Obesity Surgery (2025)
Open Access
Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects
Robert F. Kushner, Odd Erik Johansen, Krysmarú Araujo Torres, et al.
Obesities (2025) Vol. 5, Iss. 2, pp. 29-29
Open Access
Role of obesity-management medications before and after metabolic bariatric surgery: a systematic review
Ricardo V. Cohen, Ji Yeon Park, Gerhard Prager, et al.
British journal of surgery (2024) Vol. 111, Iss. 12
Open Access | Times Cited: 3
Nomogram for Predicting Suboptimal Weight Loss at Three Years after Roux-en-Y Gastric Bypass Surgery in Chinese Patients with Obesity and Type 2 Diabetes
Yiming Si, Hongwei Zhang, Xiaodong Han, et al.
Obesity Facts (2025), pp. 1-12
Open Access
Role of Incretin Mimetics in the Management of Obesity
Shilpa Chugh Garcha, Sanjay Kalra
(2025), pp. 77-100
Closed Access
Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis
Arief Arrowaili
Obesity Surgery (2025)
Closed Access
Rethinking revisional bariatric surgery: a dual approach for long-term weight control after RYGB. Paired editorial to: “Addressing recurrent weight gain after Roux-en-Y gastric bypass: efficacy of a dual surgical approach – Short term results of a single center cohort study”
Sergio Carandina, Antonio Iannelli
Surgery for Obesity and Related Diseases (2025)
Closed Access
High-dose liraglutide improves metabolic syndrome in poor responders to bariatric surgery
Federica Vinciguerra, Luigi Piazza, Carla Di Stefano, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top